CALR and colorectal cancer: Similarly, oxaliplatin upregulated cell surface calreticulin expression in colorectal cancer [31] and murine lung carcinoma cell lines [35], while docetaxel increased calreticulin cell surface expression in breast, prostate and colorectal cancer cell lines.